Association of circulatory chemerin levels with the severity of pre-eclampsia: A systematic review and bootstrapped meta-analysis
Open Access
- 13 December 2024
- journal article
- review article
- Published by Scientific Scholar in Annals of the National Academy of Medical Sciences (India)
- Vol. 60, 261-266
Abstract
Introduction: This study presents a systematic review and meta-analysis to investigate the association between circulating chemerin levels and the severity of preeclampsia (PE). Material and Methods: A thorough search was conducted across multiple databases, including PubMed/MEDLINE, SCOPUS, and the Cochrane Library, up to March 31, 2024, focusing on observational studies that compared chemerin levels in patients with severe versus mild PE. Two independent reviewers extracted mean and standard deviation (SD) values of chemerin levels from these studies. The quality and risk of bias of the included studies were assessed using the Newcastle–Ottawa Scale. Standardized mean differences (SMD) with 95% confidence intervals (CI) were calculated to evaluate the difference in chemerin levels between severe and mild PE groups. Sensitivity analyses were performed to address heterogeneity and ensure the reliability of the findings. Additionally, a bootstrapped meta-analysis with 1,000 and 10,000 simulations was conducted to further validate the results. Results: Six observational studies were included in the analysis. The findings revealed that patients with severe PE had significantly higher chemerin levels compared to those with mild PE (SMD 1.55, 95% CI 0.67–2.43, p < 0.0001). The bootstrapped meta-analysis supported the accuracy of these findings (SMD = 1.54, CI = 0.74–2.38). No publication bias was identified using Begg’s and Egger’s tests, and the sensitivity analysis confirmed the robustness of the results. Conclusion: This meta-analysis provides compelling evidence that chemerin levels are significantly elevated in patients with severe PE compared to those with mild PE. Further research is warranted to investigate the potential of circulating chemerin as a diagnostic marker for PE severity.Keywords
This publication has 18 references indexed in Scilit:
- Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptomsClinical Science, 2022
- HOXA9-induced chemerin signals through CMKLR1/AMPK/TXNIP/NLRP3 pathway to induce pyroptosis of trophoblasts and aggravate preeclampsiaExperimental Cell Research, 2021
- Prevalence of preeclampsia and the associated risk factors among pregnant women in BangladeshScientific Reports, 2021
- Chemerin promotes the pathogenesis of preeclampsia by activating CMKLR1/p-Akt/CEBPɑ axis and inducing M1 macrophage polarizationCell Biology and Toxicology, 2021
- Chemerin level in pregnancies complicated by preeclampsia and its relation with disease severity and neonatal outcomesJournal of Obstetrics and Gynaecology, 2016
- The predictive value of the first-trimester maternal serum chemerin level for pre-eclampsiaPeptides, 2014
- Chemerin plays a protective role by regulating human umbilical vein endothelial cell-induced nitric oxide signaling in preeclampsiaEndocrine, 2014
- Serum chemerin levels during normal human pregnancyPeptides, 2013
- Estimating the mean and variance from the median, range, and the size of a sampleBMC Medical Research Methodology, 2005
- Practice bulletin #33: diagnosis and management of preeclampsia and eclampsiaObstetrics & Gynecology, 2002